Source document preparation is one of the most complex, time-consuming challenges facing clinical trial sites today. As protocols grow more complex and timelines shorten, sponsor-provided source templates are gaining renewed attention as a practical solution.
In this article from the Q1 2026 edition of Pharmaceutical Outsourcing, CRIO Co-Founder and Co-CEO Raymond Nomizu explores the real-world case for sponsor involvement in source documentation, including the benefits, the risks, and the design principles that make templates work in practice.
Key topics covered:
- Why source documentation is increasingly central to trial quality and oversight
- The measurable benefits of sponsor-provided templates, from faster site startup to stronger monitoring
- Common sponsor concerns around regulatory risk and site adoption
- How CROs can bridge the gap between sponsor intent and site execution
- Design principles for templates that sites will actually use